Amgen opens new tech and innovation centre in Hyderabad

Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025
Amgen opens new technology and innovation site in Hyderabad, to invest $200 million through 2025: Our Bureau, Bengaluru Tuesday, February 25, 2025, 13:45 Hrs [IST] Amgen has opene
Drugmaker Amgen to invest $200 million in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said at the inauguration of the site on Monday.
Amgen injects $200m in Hyd with new tech centre
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre in Hyderabad.
Amgen presses on with Indian site with $200 million 2025 investment
US biotech major Amgen will invest about $200 million this year in its new technology center in southern India.
Amgen to invest $200 million in India
US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert
Amgen opens new tech and innovation centre in Hyderabad with starting investment of $200m in 2025
US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $2.
US biotech firm Amgen’s $200 million tech and innovation centre in Hyderabad inaugurated by Telangana CM
Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help the U.S. firm ramp up digital capabilities, open more opportunities for the talent pool of the region and build on the city’s position as an emerging hub for global capability centres (GCC).
Amgen plans $200M investment in India site, Reuters reports
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’
Amgen Invests $200M in India Tech Hub to Boost AI-Driven Drug Development
Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI and data-driven drug development. CEO Robert Bradway, speaking at the sites inauguration,
Hosted on MSN35m
Hyderabad will be India’s life sciences capital, says CM Reddy as BioAsia 2025 kicks off
Telangana CM says his government will create 'pharma villages', potentially creating over 5 lakh jobs, and is also ...
Telangana to Introduce India's First Life Sciences Policy: CM Revanth Reddy
Telangana Chief Minister A. Revanth Reddy has announced that the state will introduce India’s first-ever Life Sciences Policy ...
Amgen opens new technology & innovation site in Hyderabad, to invest $200 million
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...
US biotech firm Amgen to invest Rs 1,600 crore in Telangana
HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...
Top US biotech firm Amgen sets up innovation site in city
Amgen has set up this new centre in Hyderabad to further technologically develop its range of medicines. It is developing the ...